NanoCelle

B12 is a water-soluble compound, thus this foundation study was to determine NanoCelle® improvement in water-soluble compounds when compared to other more traditional forms, such as tablets, liquid emulsions, capsules, and liposomes.

Study outcomes, published, and allowed TGA to approve hieighte...

The Product - NRGBIOTIC™

PATENTED (2036), PUBLISHED CLINICAL DATA

The successful research undertaken provided for a first-in-class probiotic for the treatment of major depressive disorder, and subsequent patents in global territories, see here.

The formulation was entered into ...

Medlab Group is a private company specialising in delivery platforms, the human microbiome, and food supplement out-licencing.

NanoCelle® is a unique, patented delivery system with diverse applications.
QUICK FACTS

Improves compound solubility

Improves absorption

Reduces compound side effects

By-passes 1st pass metabolism

Improves Patient compliance

Improved onset

Significant in vitro and in vivo data

RESEARCH HAS SHOWN:

Extensive studies have been conducted, and results differ with different compounds, but over 400,000 NanoCelle® products have been dosed to patients with minimal side effects.

In vitro characterization done in collaboration with the University of Sydney

PK studies showed up too 5 times more compound is absorbed when compared to tablets, capsules, emulsions, and liposomes

Bioequivalence studies showed comparable levels to tablets 10x its dose.

Phase 1/2 studies showed safety, tolerability, and efficacy.

RWE Studies showed safety, tolerability, and efficacy over extended periods of time

The research portfolio showed no reported incident of CARPA.